Springworks Therapeutics Inc (SWTX)

$44.84 0.07 (0.16%)

16:00 EDT SWTX Stock Quote Delayed 30 Minutes

SWTX Stock Earnings: SpringWorks Therapeutics Meets EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

SWTX stock results show that SpringWorks Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

7 Biotech Stocks to Buy as Sector Rotation Ramps Up

Get In Now. 7 Stocks That Are Set to Soar.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

More Articles

Volume:

Previous Close -

Market Cap 2.20B

PE Ratio -8.71

EPS -5.15

Volume (Avg. Vol.) 693,251

Day's Range $43.80 - $44.95

52-Week Range $18.00 - $53.92

Dividend & Yield N/A (N/A)

SWTX Stock Predictions, Articles, and Springworks Therapeutics Inc News

From InvestorPlace
From the Web

7 Top-Rated Pharmaceutical Companies to Invest In for July

By Louis Navellier and the InvestorPlace Research Staff Jul 9, 2021

Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion.

7 of the Best Pharma Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff May 11, 2021

As the market gets back to normal, it's a great time to explore the pharma stocks that got lost in the vaccine frenzy of the past year.

7 Upcoming IPOs for September

By Tom Taulli, InvestorPlace Contributor Sep 10, 2019

August was a slow month for IPOs because of the vacations. But now things are back in gear. So here’s a look at the IPOs expected for September.

Investors growing more bullish on SMID cap biotech stocks (NASDAQ:ALNY)

From Seeking Alpha Feb 4, 2024

Investors are more bullish about small and mid-cap biotech stocks this year, with Merus (MRUS) and Fusion (FUSN) viewed as most likely to outperform, according to TD Cowen.

SpringWorks announces pricing of upsized public offering of common stock (NASDAQ:SWTX)

From Seeking Alpha Dec 5, 2023

SpringWorks Therapeutics announces pricing of public offering, expecting to raise approximately $275 million with 9.5 million shares at $29.00 per share.

SpringWorks Therapeutics announces proposed public offering of common stock (NASDAQ:SWTX)

From Seeking Alpha Dec 4, 2023

SpringWorks Therapeutics has commenced a $250 million public offering of its common stock, with an option for underwriters to purchase additional shares.

SpringWorks to charge $29K/month for newly approved drug: report (SWTX)

From Seeking Alpha Nov 28, 2023

SpringWorks Therapeutics (SWTX) reportedly plans to charge $29,000 per month for its newly approved drug Ogsiveo for the treatment of desmoid tumors. Read more here.

Springworks Therapeutics (SWTX) Receives a Buy from J.P. Morgan

From TipRanks Nov 10, 2022

In a report released yesterday, Anupam Rama from J.P. Morgan maintained a Buy rating on Springworks Therapeutics (SWTX – Research Report), with a price target...

H.C. Wainwright Reaffirms Their Buy Rating on Springworks Therapeutics (SWTX)

From TipRanks Nov 4, 2022

H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Springworks Therapeutics (SWTX – Research Report) today and set a price target of $99.00. The ...

ADVERTISEMENT